Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdo A Elfiky

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Journal of Medical Virology|September 8, 2016
Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trialsAbdo A Elfiky
Life Sciences|September 1, 2020
Corrigendum to "Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study" [Life Sci. 253 (2020) 117592]Abdo A Elfiky
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 17, 2018
Novel Guanosine Derivatives as Anti-HCV NS5b Polymerase: A QSAR and Molecular Docking StudyAbdo A Elfiky
Life Sciences|April 26, 2020
Reply to a letter to the editorAbdo A Elfiky
Future Microbiology|May 5, 2022
Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an <i>in silico</i> perspectiveAbdo A Elfiky
Life Sciences|March 31, 2020
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking studyAbdo A Elfiky
Journal of Medical Virology|February 29, 2020
Human papillomavirus E6: Host cell receptor, GRP78, binding site predictionAbdo A Elfiky
Life Sciences|March 3, 2020
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19Abdo A Elfiky
Frontiers in Pharmacology|December 28, 2020
SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human CoronavirusesAbdo A Elfiky
Pathology, Research and Practice|February 29, 2024
Prediction of the binding location between the nuclear inhibitor of DNA binding and differentiation 2 (ID2) and HSPA5Abdo A Elfiky
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Journal of Medical Virology|September 8, 2016
Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trialsAbdo A Elfiky
Life Sciences|September 1, 2020
Corrigendum to "Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study" [Life Sci. 253 (2020) 117592]Abdo A Elfiky
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 17, 2018
Novel Guanosine Derivatives as Anti-HCV NS5b Polymerase: A QSAR and Molecular Docking StudyAbdo A Elfiky
Life Sciences|April 26, 2020
Reply to a letter to the editorAbdo A Elfiky
Future Microbiology|May 5, 2022
Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an <i>in silico</i> perspectiveAbdo A Elfiky
Life Sciences|March 31, 2020
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking studyAbdo A Elfiky
Journal of Medical Virology|February 29, 2020
Human papillomavirus E6: Host cell receptor, GRP78, binding site predictionAbdo A Elfiky
Life Sciences|March 3, 2020
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19Abdo A Elfiky
Frontiers in Pharmacology|December 28, 2020
SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human CoronavirusesAbdo A Elfiky
Pathology, Research and Practice|February 29, 2024
Prediction of the binding location between the nuclear inhibitor of DNA binding and differentiation 2 (ID2) and HSPA5Abdo A Elfiky
Pageof 10